Cisco Systems (CSCO) “Hold” Rating Reaffirmed by Analysts at Stifel Nicolaus; With $46 Target; Tenax Therapeutics (TENX) Shorts Decreased By 9.48%

February 15, 2018 - By Nellie Frank

Tenax Therapeutics Incorporated (NASDAQ:TENX) had a decrease of 9.48% in short interest. TENX’s SI was 1.14M shares in February as released by FINRA. Its down 9.48% from 1.26M shares previously. With 311,200 avg volume, 4 days are for Tenax Therapeutics Incorporated (NASDAQ:TENX)’s short sellers to cover TENX’s short positions. The SI to Tenax Therapeutics Incorporated’s float is 6.44%. The stock 0.59% or $0 during the last trading session, reaching $0.34. It is down 81.28% since February 15, 2017 and is downtrending. It has underperformed by 97.98% the S&P500.

Among 38 analysts covering Cisco Systems Inc. (NASDAQ:CSCO), 26 have Buy rating, 0 Sell and 12 Hold. Therefore 68% are positive. Cisco Systems Inc. has $160 highest and $16 lowest target. $39.42’s average target is -10.43% below currents $44.01 stock price. Cisco Systems Inc. had 148 analyst reports since August 4, 2015 according to SRatingsIntel. The stock has “Buy” rating by Cowen & Co on Tuesday, September 5. The stock of Cisco Systems, Inc. (NASDAQ:CSCO) has “Buy” rating given on Sunday, February 11 by RBC Capital Markets. On Friday, September 23 the stock rating was maintained by Raymond James with “Outperform”. The firm has “Outperform” rating given on Thursday, May 19 by BMO Capital Markets. RBC Capital Markets maintained Cisco Systems, Inc. (NASDAQ:CSCO) rating on Wednesday, September 6. RBC Capital Markets has “Buy” rating and $36.0 target. The firm has “Buy” rating given on Wednesday, June 21 by Credit Suisse. The rating was maintained by Citigroup with “Buy” on Thursday, August 18. As per Thursday, February 11, the company rating was maintained by Deutsche Bank. The company was maintained on Friday, May 26 by Jefferies. The stock of Cisco Systems, Inc. (NASDAQ:CSCO) earned “Buy” rating by Drexel Hamilton on Friday, June 23.

Tenax Therapeutics, Inc., a specialty pharmaceutical company, focused on the identification, development, and commercialization of a portfolio of products for the critical care market in the United States and Canada. The company has market cap of $9.60 million. It focuses on the development and commercialization of pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion/5ml vial for use in the reduction of morbidity and mortality in cardiac surgery patients at risk for developing Low Cardiac Output Syndrome. It currently has negative earnings. The firm was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014.

Analysts await Cisco Systems, Inc. (NASDAQ:CSCO) to report earnings on February, 21. They expect $0.53 EPS, 0.00% or $0.00 from last year’s $0.53 per share. CSCO’s profit will be $2.62 billion for 20.76 P/E if the $0.53 EPS becomes a reality. After $0.55 actual EPS reported by Cisco Systems, Inc. for the previous quarter, Wall Street now forecasts -3.64% negative EPS growth.

Investors sentiment decreased to 1.02 in 2017 Q3. Its down 0.16, from 1.18 in 2017Q2. It dropped, as 74 investors sold Cisco Systems, Inc. shares while 637 reduced holdings. 107 funds opened positions while 619 raised stakes. 3.60 billion shares or 0.03% more from 3.60 billion shares in 2017Q2 were reported. Moreover, Stearns Fincl has 0.55% invested in Cisco Systems, Inc. (NASDAQ:CSCO) for 64,629 shares. Legal & General Grp Incorporated Public Ltd Com holds 0.68% or 26.87 million shares. Aviance Prtn Ltd Liability Company has invested 0.49% in Cisco Systems, Inc. (NASDAQ:CSCO). Alley Limited Liability accumulated 0.89% or 72,867 shares. Jupiter Asset Management has 9.83% invested in Cisco Systems, Inc. (NASDAQ:CSCO) for 8.58 million shares. Savings Bank Of Nova Scotia invested in 0.19% or 982,825 shares. Riverpoint Capital Mgmt Limited Liability Corp has invested 0.08% in Cisco Systems, Inc. (NASDAQ:CSCO). Perritt Capital invested in 0.08% or 8,956 shares. Cornerstone stated it has 0.3% in Cisco Systems, Inc. (NASDAQ:CSCO). Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Investment reported 752,000 shares or 0.24% of all its holdings. Pittenger And Anderson Incorporated holds 193,295 shares or 0.59% of its portfolio. Glenmede Co Na invested in 4.85 million shares or 0.71% of the stock. Nomura Holdg Inc holds 312,400 shares. Atalanta Sosnoff Cap Ltd Com invested in 1.48M shares. Murphy Pohlad Asset Mgmt Limited Liability Company invested in 20,288 shares or 0.47% of the stock.

Cisco Systems, Inc. designs, manufactures, and sells Internet Protocol based networking and other products related to the communications and information technology industry worldwide. The company has market cap of $217.57 billion. The firm offers switching products, including fixed-configuration and modular switches, and storage products that provide connectivity to end users, workstations, IP phones, wireless access points, and servers; and next-generation network routing products that interconnect public and private wireline and mobile networks for mobile, data, voice, and video applications. It has a 22.92 P/E ratio. It also provides collaboration products comprising unified communications products, conferencing products, collaboration endpoints, and business messaging products; data center products, such as blade and rack servers, series, fabric interconnects, and management software solutions; wireless products consisting of wireless access points, WLAN controllers, cloud and appliances based services, and integrated software services.

Since August 23, 2017, it had 0 insider buys, and 7 sales for $23.51 million activity. 23,110 shares were sold by Walker Karen, worth $740,883. CHAMBERS JOHN T also sold $7.79M worth of Cisco Systems, Inc. (NASDAQ:CSCO) shares. MCGEARY RODERICK C had sold 15,230 shares worth $578,740. CHANDLER MARK D also sold $2.11M worth of Cisco Systems, Inc. (NASDAQ:CSCO) shares. $821,900 worth of stock was sold by BHATT PRAT on Monday, September 11. Robbins Charles sold $3.89 million worth of stock or 121,390 shares. BARTZ CAROL had sold 200,000 shares worth $7.59M on Thursday, December 14.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Nellie Frank

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: